Table 1 Demographics and baseline characteristics of the included women
From: Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear
Variables | Women (n = 507) | |
|---|---|---|
Age (Year), mean ± SD | 38.7 ± 8.5 | |
Ethnicity, N (%) | Arab | 402 (79.3) |
Indian | 16 (3.1) | |
Asian | 57 (11.2) | |
African | 2 (0.4) | |
Caucasian | 11 (2.2) | |
Other | 19 (3.7) | |
Smoking, N (%) | 24 (4.7) | |
Parity, mean ± SD | 2.7 ± 1.9 | |
Abnormal vaginal bleeding, N (%) | 114 (22.5) | |
Postcoital bleeding, N (%) | 73 (14.4) | |
Contraception, N (%) | 79 (15.6) | |
Contraception type, N (%) | Combined contraceptives | 42 (8.3) |
IUCD | 30 (5.9) | |
IMPLANON/DEPO/pop | 6 (1.2) | |
Known HIV, N (%) | 1 (0.2) | |
HPV/vaginal warts, N (%) | 16 (3.2) | |
Immunosuppressant use, N (%) | 7 (1.4) | |
HPV vaccination, N (%) | 6 (1.2) | |
Previous Smear, N (%) | 136 (26.8) | |
Smear Results*, N (%) | Normal | 106 (77.9) |
Abnormal | 25 (18.7) | |
Unsatisfactory | 1 (0.7) | |
Previous HPV test, N (%) | 9 (1.8) | |